HOME >> MEDICINE >> NEWS
New research shows major sleep disturbances overlooked in management of patients with Parkinson's disease

Once Daily Cabergoline Successfully Controls Sleep Disturbances

Up to 96 percent of patients with Parkinson's disease (PD) experience serious sleep disturbances caused by many factors,1 however, these symptoms are often overlooked by doctors. As a consequence many patients suffer from excessive daytime sleepiness, impaired cognitive ability and an overall diminished quality of life, warned researchers presenting at the International Congress of the European Federation of Neurological Societies (14th-18th October, 2000; Copenhagen).

To improve PD management, researchers presented encouraging findings on new ways of monitoring PD symptoms, including sleep disturbance and motor problems. In two separate presentations, researchers presented data using a newly designed Parkinson's Disease Sleep Scale (PDSS), a patient-administered questionnaire which could help clinicians diagnose nocturnal disability quickly and provide a useful tool to monitor response to treatment. Actigrapy, the second test discussed, measures limb motor activity and circadian variations by use of a special device called an Actigraph. Using both testing methods, investigators evaluated the efficacy of the long-acting dopamine agonist cabergoline (CABASER/CABASERIL tablets) on sleep disturbances in PD patients and found cabergoline offers important benefits, possibly due to its long duration of action, in achieving significant improvement of the symptoms underlying PD during the night as well as the day.

Dr K. Ray Chaudhuri, Consultant and Honorary Senior Lecturer at Kings College Hospital, London, explained that current methods lack quantitative aspects, thereby making them inadequate for the precise assessment of symptoms and treatment. The most commonly employed sleep questionnaire that is traditionally used in clinical practice is the Epworth Sleepiness Scale (ESS). Although motor disturbances are an important cause of sleep disturbance, the ESS scale o
'"/>

Contact: Roseann Ward
roseann.ward@ketchumcomms.co.uk
44-207-465-8752
Ketchum
24-Oct-2000


Page: 1 2 3 4

Related medicine news :

1. Public morally obliged to take part in scientific research, says leading ethicist
2. U of M researcher says Viagra may cause permanent vision loss in some men
3. Indiana University researchers closer to helping hearing-impaired using stem cells
4. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
5. RIT takes eye-tracking research to next level
6. UW research shows risk factors for relapse among health care professionals who abuse drugs
7. Protein that helps skin cancer spread identified by Stanford researchers
8. US life expectancy about to decline, researchers say
9. Ethical discussion should come before research
10. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
11. Gene for age-related macular degeneration discovered by Yale researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... Grove Village, IL (PRWEB) , ... January 16, ... ... and personal audio products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs ... and Convention Center in Las Vegas, Booth #2809. The SHOT Show is the ...
(Date:1/16/2017)... ... January 16, 2017 , ... As New York’s fastest growing ... MD to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, ... a division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, ...
(Date:1/16/2017)... , ... January 16, 2017 , ... St. Louisans are well-aware of the following facts ... This year’s influenza shot seems to be having no effect on keeping this particularly ... half of the people around are coughing, sneezing, or sniffling , These ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all types of ... test for, as well. The money spent screening for and treating cancer in the ... screen patients for cancer more than in any other country that has an advanced ...
(Date:1/15/2017)... , ... January 15, 2017 , ... In this role, ... the United States for the asthma & allergy friendly mark. This certification program was ... test and identify consumer products to be more suitable for the 60+ million people ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , January 17, 2017 ... 1):2-4 ; http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ... ... recently in European Neurological Review ... Catherine Amey reports that despite standard ...
(Date:1/17/2017)... January 17, 2017 Transparency Market Research has ... Acid, Sodium Benzoate, Benzyl Alcohol and Others) Market - Global Industry ... report, the global benzaldehyde derivative market was valued at ... 2.14 Bn by 2024, expanding at a CAGR of 5.1 % ... ...
(Date:1/17/2017)... DUBLIN and BUDAPEST, Hungary , ... ) and Gedeon Richter Plc. today announced positive results from ... trials evaluating the efficacy and safety of ulipristal acetate in ... drug application filing for ulipristal acetate is planned for the ... the favorable results of Venus II supporting the efficacy and ...
Breaking Medicine Technology:
Cached News: